Melox (Meloxicam)

Meloxicam works by reversibly inhibiting cyclooxygenase enzymes, especially COX‑2. This inhibition reduces the production of prostaglandins, which are chemical mediators that cause inflammation, pain, and fever. By lowering prostaglandin levels, meloxicam diminishes the inflammatory response and provides analgesic relief.

The specific dose of Melox is determined by the prescribing clinician based on the patient’s condition, severity of symptoms, and overall health status. Dosage may vary according to indication and individual response, and it should always follow the prescriber’s written instructions.

Safety data for meloxicam in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Melox, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including cold‑chain handling if needed) and assists with import documentation.

Melox (meloxicam) offers relatively greater COX‑2 selectivity compared with non‑selective NSAIDs such as ibuprofen or naproxen, which may translate into a lower incidence of gastrointestinal irritation. However, it shares similar cardiovascular and renal risk profiles with other NSAIDs, and the choice of agent should consider individual patient risk factors and therapeutic goals.

Melox should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the product in its original packaging until use, and ensure that temperature monitoring is maintained throughout transport and storage to preserve potency.

Melox is administered by a qualified healthcare professional as an intramuscular injection. The injection site is typically a large muscle such as the gluteus or deltoid, and the volume and technique follow standard aseptic practices. The exact administration schedule is determined by the prescriber.

Serious risks associated with Melox include gastrointestinal bleeding or ulceration, severe skin reactions such as Stevens‑Johnson syndrome, renal impairment, hepatotoxicity, and anaphylactic hypersensitivity. Patients should be monitored for signs of bleeding, skin rash, changes in urine output, or liver dysfunction, and the drug should be discontinued if any serious reaction occurs.

Melox should be avoided in patients with known hypersensitivity to meloxicam or other NSAIDs, those with active peptic ulcer disease, severe uncontrolled hypertension, recent myocardial infarction, or significant renal or hepatic impairment. It is also contraindicated in individuals receiving certain anticoagulants or other COX‑2 selective agents without careful medical supervision.